Adverum Biotechnologies Stock Price History
| ADVM Stock | USD 11.15 0.20 1.76% |
Below is the normalized historical share price chart for Adverum Biotechnologies extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adverum Biotechnologies stands at 11.15, as last reported on the 18th of April 2024, with the highest price reaching 11.58 and the lowest price hitting 11.01 during the day.
If you're considering investing in Adverum Stock, it is important to understand the factors that can impact its price. Adverum Biotechnologies appears to be unstable, given 3 months investment horizon. Adverum Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.0907, which signifies that the company had a 0.0907% return per unit of risk over the last 3 months. By analyzing Adverum Biotechnologies' technical indicators, you can evaluate if the expected return of 0.83% is justified by implied risk. Please makes use of Adverum Biotechnologies' Mean Deviation of 5.7, risk adjusted performance of 0.0667, and Downside Deviation of 6.31 to double-check if our risk estimates are consistent with your expectations.
At this time, Adverum Biotechnologies' Common Stock Shares Outstanding is very stable compared to the past year. As of the 18th of April 2024, Liabilities And Stockholders Equity is likely to grow to about 247.9 M, while Other Stockholder Equity is likely to drop about 567.3 M. . At this time, Adverum Biotechnologies' Price Book Value Ratio is very stable compared to the past year. As of the 18th of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price Earnings Ratio is likely to drop (0.68). Adverum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of July 2014 | 200 Day MA 13.9979 | 50 Day MA 17.271 | Beta 0.793 |
Adverum |
Sharpe Ratio = 0.0907
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ADVM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.17 actual daily | 81 81% of assets are less volatile |
Expected Return
| 0.83 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Adverum Biotechnologies is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adverum Biotechnologies by adding it to a well-diversified portfolio.
Price Book 2.9167 | Enterprise Value Ebitda (1.88) | Price Sales 67.6264 | Shares Float 11.7 M | Wall Street Target Price 40 |
Adverum Biotechnologies Stock Price History Chart
There are several ways to analyze Adverum Stock price data. The simplest method is using a basic Adverum candlestick price chart, which shows Adverum Biotechnologies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 7, 2024 | 28.1 |
| Lowest Price | January 23, 2024 | 8.64 |
Adverum Biotechnologies April 18, 2024 Stock Price Synopsis
Various analyses of Adverum Biotechnologies' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Adverum Stock. It can be used to describe the percentage change in the price of Adverum Biotechnologies from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Adverum Stock.| Adverum Biotechnologies Accumulation Distribution | 5,099 | |
| Adverum Biotechnologies Price Daily Balance Of Power | (0.35) | |
| Adverum Biotechnologies Price Rate Of Daily Change | 0.98 | |
| Adverum Biotechnologies Price Action Indicator | (0.24) |
Adverum Biotechnologies April 18, 2024 Stock Price Analysis
Adverum Stock Price History Data
The price series of Adverum Biotechnologies for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 has a statistical range of 20.1 with a coefficient of variation of 30.03. The prices are distributed with arithmetic mean of 15.44. The median price for the last 90 days is 15.2. The company had 1:10 stock split on 21st of March 2024.| Open | High | Low | Close | Volume | ||
| 04/18/2024 | 11.35 | 11.58 | 11.01 | 11.15 | 103,592 | |
| 04/17/2024 | 11.64 | 11.68 | 11.22 | 11.35 | 67,952 | |
| 04/16/2024 | 11.52 | 12.02 | 11.43 | 11.61 | 60,857 | |
| 04/15/2024 | 11.72 | 12.09 | 11.37 | 11.53 | 99,363 | |
| 04/12/2024 | 11.95 | 12.24 | 11.52 | 11.73 | 151,342 | |
| 04/11/2024 | 12.01 | 12.06 | 11.46 | 11.97 | 280,188 | |
| 04/10/2024 | 11.91 | 12.31 | 11.44 | 11.98 | 371,246 | |
| 04/09/2024 | 12.53 | 12.72 | 11.87 | 12.01 | 511,262 | |
| 04/08/2024 | 12.67 | 13.14 | 12.34 | 12.58 | 213,833 | |
| 04/05/2024 | 13.21 | 13.40 | 12.57 | 12.62 | 241,560 | |
| 04/04/2024 | 13.36 | 14.16 | 13.08 | 13.17 | 166,112 | |
| 04/03/2024 | 13.40 | 13.61 | 13.13 | 13.35 | 167,247 | |
| 04/02/2024 | 13.67 | 13.67 | 13.19 | 13.40 | 102,681 | |
| 04/01/2024 | 14.21 | 14.21 | 13.70 | 13.89 | 174,556 | |
| 03/28/2024 | 14.63 | 14.82 | 13.83 | 14.14 | 109,879 | |
| 03/27/2024 | 14.16 | 15.16 | 13.73 | 14.66 | 166,895 | |
| 03/26/2024 | 14.92 | 14.92 | 13.67 | 14.15 | 682,659 | |
| 03/25/2024 | 15.75 | 16.43 | 14.86 | 14.95 | 357,284 | |
| 03/22/2024 | 14.31 | 16.48 | 14.00 | 16.06 | 576,559 | |
| 03/21/2024 | 15.69 | 17.65 | 14.52 | 14.75 | 256,650 | |
| 03/20/2024 | 1.60 | 15.20 | 15.20 | 15.20 | 216,892 | |
| 03/19/2024 | 15.00 | 18.00 | 14.00 | 16.50 | 408,678 | |
| 03/18/2024 | 17.20 | 17.90 | 16.55 | 17.70 | 144,713 | |
| 03/15/2024 | 1.75 | 17.00 | 17.00 | 17.00 | 830,109 | |
| 03/14/2024 | 1.78 | 17.30 | 17.30 | 17.30 | 162,721 | |
| 03/13/2024 | 1.80 | 18.00 | 18.00 | 18.00 | 164,347 | |
| 03/12/2024 | 1.82 | 18.10 | 18.10 | 18.10 | 89,082 | |
| 03/11/2024 | 1.86 | 17.90 | 17.90 | 17.90 | 94,511 | |
| 03/08/2024 | 1.95 | 18.80 | 18.80 | 18.80 | 128,728 | |
| 03/07/2024 | 1.85 | 19.20 | 19.20 | 19.20 | 132,345 | |
| 03/06/2024 | 1.90 | 18.50 | 18.50 | 18.50 | 131,498 | |
| 03/05/2024 | 1.94 | 18.80 | 18.80 | 18.80 | 117,829 | |
| 03/04/2024 | 1.99 | 19.70 | 19.70 | 19.70 | 261,143 | |
| 03/01/2024 | 1.98 | 19.70 | 19.70 | 19.70 | 101,303 | |
| 02/29/2024 | 1.98 | 19.80 | 19.80 | 19.80 | 90,253 | |
| 02/28/2024 | 2.04 | 19.70 | 19.70 | 19.70 | 116,899 | |
| 02/27/2024 | 2.00 | 20.00 | 20.00 | 20.00 | 136,850 | |
| 02/26/2024 | 1.99 | 19.50 | 19.50 | 19.50 | 89,356 | |
| 02/23/2024 | 2.10 | 20.00 | 20.00 | 20.00 | 109,401 | |
| 02/22/2024 | 1.98 | 21.00 | 21.00 | 21.00 | 133,199 | |
| 02/21/2024 | 1.91 | 19.70 | 19.70 | 19.70 | 151,885 | |
| 02/20/2024 | 2.03 | 19.60 | 19.60 | 19.60 | 129,559 | |
| 02/16/2024 | 2.00 | 20.30 | 20.30 | 20.30 | 297,013 | |
| 02/15/2024 | 2.18 | 20.00 | 20.00 | 20.00 | 547,263 | |
| 02/14/2024 | 2.23 | 21.00 | 21.00 | 21.00 | 238,685 | |
| 02/13/2024 | 1.90 | 22.90 | 22.90 | 22.90 | 341,189 | |
| 02/12/2024 | 1.84 | 19.90 | 19.90 | 19.90 | 232,635 | |
| 02/09/2024 | 1.91 | 17.30 | 17.30 | 17.30 | 394,028 | |
| 02/08/2024 | 2.95 | 19.70 | 19.70 | 19.70 | 1,518,409 | |
| 02/07/2024 | 2.43 | 28.10 | 28.10 | 28.10 | 670,448 | |
| 02/06/2024 | 1.99 | 25.00 | 25.00 | 25.00 | 689,945 | |
| 02/05/2024 | 1.71 | 19.10 | 19.10 | 19.10 | 2,414,665 | |
| 02/02/2024 | 1.20 | 14.20 | 14.20 | 14.20 | 269,010 | |
| 02/01/2024 | 1.04 | 11.90 | 11.90 | 11.90 | 126,500 | |
| 01/31/2024 | 1.07 | 10.50 | 10.50 | 10.50 | 53,134 | |
| 01/30/2024 | 1.09 | 10.60 | 10.60 | 10.60 | 84,782 | |
| 01/29/2024 | 0.96 | 10.70 | 10.70 | 10.70 | 126,193 | |
| 01/26/2024 | 0.90 | 9.40 | 9.40 | 9.40 | 39,766 | |
| 01/25/2024 | 0.91 | 8.95 | 8.95 | 8.95 | 123,202 | |
| 01/24/2024 | 0.88 | 9.09 | 9.09 | 9.09 | 43,500 | |
| 01/23/2024 | 0.87 | 8.64 | 8.64 | 8.64 | 35,088 |
About Adverum Biotechnologies Stock history
Adverum Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adverum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adverum Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adverum Biotechnologies stock prices may prove useful in developing a viable investing in Adverum Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.1 M | 18.4 M | |
| Net Loss | -139.1 M | -146 M |
Adverum Biotechnologies Quarterly Net Working Capital |
|
Adverum Biotechnologies Stock Technical Analysis
Adverum Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Adverum Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adverum Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adverum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adverum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0667 | |||
| Jensen Alpha | 0.7956 | |||
| Total Risk Alpha | 0.1605 | |||
| Sortino Ratio | 0.1213 | |||
| Treynor Ratio | 2.52 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Adverum Stock analysis
When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.60) | Revenue Per Share 0.357 | Quarterly Revenue Growth (0.70) | Return On Assets (0.32) | Return On Equity (0.88) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.